Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease
Clinical trial NCT01218659 · COMPLETED
Trial details
- NCT number
- NCT01218659
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-08
- Primary completion
- 2014-05-27
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.